Aardvark Therapeutics

Pharmaceutical Manufacturing

San Diego, California 1,084 followers

Rethinking Metabolic Health

Discover all 19 employees

About us

Aardvark Therapeutics is a clinical-stage biopharmaceutical company developing novel, small-molecule therapies designed to inhibit hunger and transform metabolic health

Website: https://aardvarktherapeutics.com/
External link for Aardvark Therapeutics
Industry: Pharmaceutical Manufacturing
Company size: 11-50 employees
Headquarters: San Diego, California
Type: Privately Held
Founded: 2017

Locations

Primary

4370 La Jolla Village Dr

1050

San Diego, California 92121, US

Get directions

Employees at Aardvark Therapeutics

See all employees

Updates

Aardvark Therapeutics

1,084 followers
2mo
Report this post
Dr. Tien Lee, Founder and CEO of Aardvark Therapeutics, joined Judy Shaw on #NYSEFloorTalk to talk about their innovative obesity drug, ARD-101. He shared how it stands out from other treatments, the encouraging data so far, and what their upcoming trials will focus on.

NYSE

321,127 followers
4mo Edited

Dr. Tien Lee, Founder and CEO of Aardvark Therapeutics, joined Judy Khan Shaw on #NYSEFloorTalk to talk about their innovative obesity drug, ARD-101. He shared how it stands out from other treatments, the encouraging data so far, and what their upcoming trials will focus on.

Floor Talk with Dr. Tien Lee, CEO of Aardvark Therapeutics

1 Comment

Like Comment Share
Aardvark Therapeutics

1,084 followers
5mo
Report this post
Tien Lee, Founder and CEO of Aardvark Therapeutics, joins Nasdaq to celebrate our recent funding and discusses how our company specializes in gut brain interaction with a focus of inflammation and metabolism. #aardvarktherapeutics

Nasdaq

510,437 followers
5mo

Tien Lee, Founder and CEO of Aardvark Therapeutics, joins Nasdaq to celebrate their recent funding and discuss how the company specializes in gut brain interaction with a focus of inflammation and metabolism. Watch more: https://lnkd.in/eQK-Jv-N

2 Comments

Like Comment Share

Funding

Aardvark Therapeutics 3 total rounds

Last Round

Series C Jun 9, 2024

US$ 85.0M

Investors

Decheng Capital + 11 Other investors

See more info on crunchbase

Aardvark Therapeutics

Pharmaceutical Manufacturing

San Diego, California 1,084 followers

Rethinking Metabolic Health

About us

Locations

Employees at Aardvark Therapeutics

Jeff Chi

Vice Chairman & Founding Partner at Vickers Venture Partners

Tien Lee

Ronald D. Lewis, II, Ph.D.

Technical & CMC Operations Lead | Non-Profit Board Member | Alzheimer’s and Dementia Patient & Caregiver Advocate | STEM Educator

Jeff Oster

general counsel and co-founder at Aardvark Therapeutics

Updates

Floor Talk with Dr. Tien Lee, CEO of Aardvark Therapeutics

Join now to see what you are missing

Similar pages

Bluejay Therapeutics

Attovia Therapeutics

Zenas BioPharma

R3 Vascular Inc.

ADC Therapeutics

Cellectis

Optinose

Enlaza Therapeutics

Alterome Therapeutics, Inc

Endeavor BioMedicines

Funding